Format

Send to

Choose Destination
EBioMedicine. 2016 Feb 9;4:7-8. doi: 10.1016/j.ebiom.2016.02.016. eCollection 2016 Feb.

Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis.

Author information

1
Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
2
Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
PMID:
26981560
PMCID:
PMC4776226
DOI:
10.1016/j.ebiom.2016.02.016
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center